Inventia Healthcare Chlorthalidone Tablets
Chlorthalidone Tablets failed dissolution specifications.
Moderate risk
Taking it may cause temporary or medically reversible health problems. Serious harm is unlikely.
FDA Class II recall · How risk is rated
What happened
Inventia Healthcare Limited, of Kalyan, India, recalled Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, because the product failed dissolution specifications. The company began the recall on September 3, 2026, and the FDA added it to the Enforcement Report on September 16, 2026. The recall involved 13,567 bottles distributed nationwide in the U.S.
Summary by Recall Canary from the FDA notice.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is your bottle affected?
Match the NDC and lot code listed under your product.
Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle
- NDC
- 64980-599-01
- Lot
- RISA24002
Details
- Company began the recall
- Sold in
U.S. Nationwide
- Event ID
- 99806
- Recall No.
- D-0852-2026
- Company
- Inventia Healthcare LimitedKalyan, India
- Hazard
- Dissolution failure
- Quantity recalled
- 13567 bottles
Company began the recall
Added to FDA's Enforcement Report
Classified by FDA · Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
